TheMissing Fifth
UNILEVER BOUGHT AN OPERATOR,
NOT A BRAND. THE FIFTH PROVES IT
I am not a neutral reader here and would rather say so first. I take around fifteen things every day, I read the mechanism on each before it goes in, and I get bloodwork drawn to check whether any of it does what it claims. So when Unilever completed its acquisition of Grüns on the first of June, another shelf in my own bathroom changed owner. I do not think Unilever bought a brand at all. It bought an operator, and the one fifth it deliberately left behind is the evidence.
The denominator nobody checked
Grüns was founded in 2023 by Chad Janis, sells a daily greens supplement in gummy form almost entirely by subscription, reached roughly three hundred million dollars of annual revenue in under four years, and was reported profitable inside about fourteen months. The deal came out around one point two billion dollars.
Then nearly everyone ran the same sum. One point two over three hundred, four times sales, sensible bolt on, move along. Trade reporting places that consideration against eighty percent of the shares rather than all of them. If that holds, the whole company is nearer one and a half billion and the multiple is closer to five than four. I could not confirm the split in Unilever's own half year filing, which records completion and says nothing about terms, so I flag it rather than bank it. But the number is not the interesting part. The structure is.
You do not leave a fifth behind by accident
A full turn of revenue is the distance between a bolt on price and a growth price. What explains paying a growth price and still not taking the whole thing?
My read is that the retained fifth is a retention device, and that tells you what the asset actually was. Grüns is three years old, founder run, and the whole business is a subscription machine somebody has been operating with unusual discipline for a very short time. You do not buy that outright when what you need is for the operator to stay in the building. Unilever bought execution, and execution walks out of the door unless you give it a reason to stay.
Which is exactly why I am watching the label
If the thesis is right, then everything I care about as a customer rests on the same fifth. A greens gummy is a formulation, and formulations get revisited. Under a founder the reason to change one is usually efficacy. Under a large consumer owner with a cost line to manage, the reason can be margin.
So the retention device is not just a deal term, it is the thing standing between the product I buy and the ordinary gravity of a large portfolio. I have no evidence that anything has changed or is planned, and I want that stated plainly rather than implied. But my concern is specific and it has a date attached: not what happens now, but what happens when that fifth is finally bought and the founder has no remaining reason to defend the formula.
My call
A good price for Unilever while the operator stays, which is a narrower dependency than four times revenue implies and narrower still at five. I would not watch revenue. I would watch for the announcement that the remaining stake has been acquired, because that is the moment the protection expires.
They bought execution, and execution walks out of the door unless you give it a reason to stay.
Sources
- Unilever Form 6-K, half year results to 30 June 2026, confirming completion in June 2026 and not stating terms.
- Consideration, revenue scale and the eighty percent stake are from trade reporting rather than the filing, and are treated here as reported rather than confirmed.